Home » Topics » BioWorld

BioWorld
RSS

APPOINTMENTS AND ADVANCEMENTS

Jan. 13, 1992

SUGEN RAISES $2.3 MILLION

Jan. 13, 1992

MUREX RAISES $10M IN OVERALLOTMENT SALE

Jan. 13, 1992

UNISYN COMPLETES BIOPROBE ACQUISITION

Jan. 10, 1992

SHAREHOLDERS OK STOCK SPLIT

Jan. 10, 1992

DEPRENYL, CANGUARD TO SETTLE OUT OF COURT

Jan. 10, 1992

INNOVET IMMUNOSTIMULANT VS. TUMORS

Jan. 10, 1992

ENZON TO COLLABORATE WITH ALLELIX

Jan. 10, 1992

APPLIED IMMUNE FILES FOR OFFERING

Jan. 10, 1992

DNX PIGS WITH MORE HUMAN HEMOGLOBIN

Jan. 10, 1992

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...